These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12680564)

  • 21. A 'systems approach' to vaccines.
    Nat Immunol; 2006 Sep; 7(9):891. PubMed ID: 16924246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sharing the benefits of HIV/AIDS research with resource-poor countries: AZT for pregnant women in Africa?
    Needham DM
    Hum Health Care Int; 1997; 13(3):E11. PubMed ID: 14986616
    [No Abstract]   [Full Text] [Related]  

  • 23. The vaccine research community rebuilds its agenda.
    McCord A
    Proj Inf Perspect; 2008 Sep; (46):21-2. PubMed ID: 19048678
    [No Abstract]   [Full Text] [Related]  

  • 24. AIDS research cut to pay for anthrax vaccine.
    Check E
    Nature; 2003 Jul; 424(6946):241. PubMed ID: 12867943
    [No Abstract]   [Full Text] [Related]  

  • 25. AIDS vaccine research. Thumbs down on expensive, hotly debated trial of NIH AIDS vaccine.
    Cohen J
    Science; 2008 Jul; 321(5888):472. PubMed ID: 18653850
    [No Abstract]   [Full Text] [Related]  

  • 26. Bridging the gap between "ABC" and an AIDS vaccine.
    Laurence J
    AIDS Read; 2006 Oct; 16(10):502-4. PubMed ID: 17096468
    [No Abstract]   [Full Text] [Related]  

  • 27. US plans more primate research.
    Hayden EC
    Nature; 2008 May; 453(7194):439. PubMed ID: 18497784
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccine research groups declare collaboration.
    AIDS Policy Law; 2008 May; 23(6):1. PubMed ID: 18581627
    [No Abstract]   [Full Text] [Related]  

  • 29. AIDS vaccine group expands operations in New York.
    Opar A
    Nat Med; 2007 Jun; 13(6):654. PubMed ID: 17554321
    [No Abstract]   [Full Text] [Related]  

  • 30. What to do with $88 million?
    Lett D
    CMAJ; 2010 Jun; 182(9):E415-6. PubMed ID: 20479051
    [No Abstract]   [Full Text] [Related]  

  • 31. AIDS-vaccine firm needled by stock-exchange rules.
    Nature; 2004 May; 429(6990):335. PubMed ID: 15164031
    [No Abstract]   [Full Text] [Related]  

  • 32. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 34. A developing theme for AIDS.
    Watanabe M
    Nature; 2003 Dec; 426(6967):736-7. PubMed ID: 14668887
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccine failure is not a 'crisis' for HIV research.
    Jefferys R
    Nature; 2008 Jun; 453(7196):719-20. PubMed ID: 18528370
    [No Abstract]   [Full Text] [Related]  

  • 36. NIAID funds center for HIV/AIDS vaccine immunology.
    AIDS Policy Law; 2005 Jul; 20(14):2. PubMed ID: 16108120
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV vaccine research a shot in the arm for immunologists.
    Check E
    Nat Med; 2004 Dec; 10(12):1268. PubMed ID: 15580236
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine research lines converge. Vaccinologists working on different diseases met in Germany to exchange ideas--and found that their approaches already have a great deal in common.
    Cohen P
    IAVI Rep; 2005; 9(4):1, 6-9. PubMed ID: 16465684
    [No Abstract]   [Full Text] [Related]  

  • 39. 'Money down the drain' fears for AIDS vaccine trials.
    Nature; 2003 Nov; 426(6964):220-1. PubMed ID: 14628016
    [No Abstract]   [Full Text] [Related]  

  • 40. A strategy for developing an HIV vaccine.
    The
    PLoS Med; 2005 Jan; 2(1):e35. PubMed ID: 15696213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.